Literature DB >> 10694488

Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease.

I Lappalainen1, S Giliani, R Franceschini, J Y Bonnefoy, C Duckett, L D Notarangelo, M Vihinen.   

Abstract

X-linked lymphoproliferative disease (XLP) is a rare and severe immune deficiency, characterized by abnormal immune responses to the Epstein-Barr virus. Recently, the gene responsible for XLP, SH2D1A, has been identified and shown to code for a small cytoplasmic protein with an SH2 domain that interacts with SLAM and 2B4, two receptorial molecules involved in signal transduction in T and NK cells, respectively. A variety of SH2D1A gene mutations have been reported thus far in XLP males. Here we describe a single-strand conformation polymorphism assay for mutation analysis in XLP. Four novel patients with SH2D1A mutations are described. These mutants, and the others previously reported in the literature, have been included in a Registry (SH2D1Abase) that is fully accessible on the World Wide Web. A three-dimensional model of the SH2 domain of the SH2D1A protein has been developed, based on homology with other SH2 domains. The structural consequences of disease-causing SH2D1A mutations are discussed. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694488     DOI: 10.1006/bbrc.2000.2146

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  The genetics of familial lymphomas.

Authors:  Rina Siddiqui; Kenan Onel; Flavia Facio; Kenneth Offit
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

2.  Bioinformatic analysis of pathogenic missense mutations of activin receptor like kinase 1 ectodomain.

Authors:  Claudia Scotti; Carla Olivieri; Laura Boeri; Cecilia Canzonieri; Federica Ornati; Elisabetta Buscarini; Fabio Pagella; Cesare Danesino
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

3.  First Report of an SH2D1A Mutation Associated with X-Linked Lymphoproliferative Disease in Turkey

Authors:  Selman Kesici; Ebru Yılmaz Keskin; Samuel C.C. Chiang; Çiğdem Seher Kasapkara; Takuya Sekine; Meltem Akçaboy; Ali Fettah; Yenan T. Bryceson
Journal:  Turk J Haematol       Date:  2018-02-02       Impact factor: 1.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.